Drug Profile
ASP 5878
Alternative Names: ASP-5878Latest Information Update: 24 Feb 2021
Price :
$50
*
At a glance
- Originator Astellas Pharma
- Developer Astellas Pharma; Kyoto University
- Class Alcohols; Amines; Antineoplastics; Ethers; Fluorobenzenes; Pyrazoles; Pyrimidines; Small molecules
- Mechanism of Action Type 1 fibroblast growth factor receptor antagonists; Type 3 fibroblast growth factor receptor antagonists; Type 4 fibroblast growth factor receptor antagonists; Type-2 fibroblast growth factor receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Achondroplasia
- Discontinued Solid tumours